| 2025 | 2024 | 2023 | 2022 | 2021 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 59,4 k € | +3.4% | 57,5 k € | +1.5% | 56,6 k € | +9.8% | 51,5 k € | +4.7% | 49,2 k € | +6.8% | 46,1 k € | +3.5% | 44,6 k € | -0.5% | 44,8 k € | +5.0% | 42,7 k € | +0.5% | 42,4 k € | -5.3% | 44,8 k € | +23.7% | 36,2 k € | -18.1% | 44,2 k € | -13.1% | 50,8 k € | +32.4% | 38,4 k € | -12.8% | 44,0 k € | -29.2% | 62,2 k € | |
| EBITDA | 56,6 k € | +3.5% | 54,7 k € | +3.2% | 53,0 k € | +8.4% | 48,9 k € | +4.4% | 46,8 k € | +6.7% | 43,9 k € | +3.6% | 42,3 k € | -0.6% | 42,6 k € | +5.2% | 40,5 k € | +0.8% | 40,2 k € | -7.6% | 43,5 k € | +22.2% | 35,6 k € | -18.2% | 43,5 k € | -6.3% | 46,4 k € | +23.0% | 37,7 k € | -12.5% | 43,1 k € | -29.3% | 61,0 k € | |
| Operating profit | 48,6 k € | +6.4% | 45,7 k € | +3.8% | 44,0 k € | +10.3% | 39,9 k € | +5.5% | 37,8 k € | +7.4% | 35,2 k € | +4.6% | 33,7 k € | +38.3% | 24,3 k € | +28.6% | 18,9 k € | -3.5% | 19,6 k € | +30.7% | 15,0 k € | +150.5% | 6,0 k € | -62.1% | 15,8 k € | -7.2% | 17,0 k € | +192.6% | 5,8 k € | -53.7% | 12,6 k € | -47.5% | 24,0 k € | |
| Profit/loss | 35,7 k € | +9.7% | 32,6 k € | +7.0% | 30,4 k € | +12.1% | 27,1 k € | +8.4% | 25,0 k € | +28.4% | 19,5 k € | +14.8% | 17,0 k € | +94.9% | 8,7 k € | +8.6% | 8,0 k € | +6.4% | 7,5 k € | +197.0% | 2,5 k € | +143.2% | -5,9 k € | -256.9% | 3,8 k € | -24.0% | 4,9 k € | +175.7% | -6,5 k € | -313.4% | -1,6 k € | -118.0% | 8,8 k € | |
| Equity | 281,3 k € | +14.6% | 245,5 k € | +15.3% | 212,9 k € | +16.7% | 182,5 k € | +17.5% | 155,3 k € | +82.0% | 85,3 k € | +29.6% | 65,8 k € | +34.8% | 48,8 k € | +21.7% | 40,1 k € | +25.0% | 32,1 k € | +30.8% | 24,5 k € | +11.6% | 22,0 k € | -21.1% | 27,9 k € | +15.6% | 24,1 k € | +25.7% | 19,2 k € | -25.4% | 25,7 k € | -5.8% | 27,3 k € | |
| Total assets | 431,3 k € | +3.9% | 415,3 k € | +4.2% | 398,6 k € | +3.5% | 385,0 k € | +2.9% | 374,1 k € | +5.4% | 354,9 k € | +0.2% | 354,2 k € | +1.6% | 348,6 k € | -9.7% | 386,1 k € | -5.0% | 406,4 k € | -6.5% | 434,6 k € | -15.6% | 515,1 k € | +199.2% | 172,2 k € | -9.2% | 189,7 k € | -16.3% | 226,6 k € | -1.6% | 230,2 k € | -7.6% | 249,1 k € | |
| Cash | 15,6 k € | +36.6% | 11,4 k € | +219.4% | 3,6 k € | -36.2% | 5,6 k € | -61.1% | 14,4 k € | +118.4% | 6,6 k € | -65.1% | 18,8 k € | -3.3% | 19,5 k € | -33.8% | 29,4 k € | +23.5% | 23,8 k € | +63.0% | 14,6 k € | +150.7% | 5,8 k € | +5.1% | 5,5 k € | -18.0% | 6,8 k € | -43.5% | 12,0 k € | +933.5% | 1,2 k € | -85.5% | 8,0 k € | |
| Debts | 150,1 k € | -11.4% | 169,3 k € | -8.8% | 185,7 k € | -8.3% | 202,5 k € | -7.4% | 218,8 k € | -18.9% | 269,6 k € | -6.5% | 288,4 k € | -3.8% | 299,7 k € | -13.4% | 346,0 k € | -7.6% | 374,3 k € | -8.7% | 410,1 k € | -16.8% | 493,1 k € | +244.0% | 143,4 k € | -12.9% | 164,5 k € | -19.5% | 204,4 k € | +0.3% | 203,8 k € | -8.0% | 221,6 k € | |
Private limited company · Oostende · incorporated on 12/09/2006
Private limited company profitable and well capitalised. Cash position rising (+36.6%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
APOTHEEK PERSYN is a Private limited company incorporated in 2006. Its main activity is: Leasing of intellectual property and similar products, except copyrighted works. Its registered office is in Oostende.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette